Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty - Takeaways - MDSpire

Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty

  • By

  • Ce Huang

  • Yingqian Zhu

  • Xue Gong

  • Shengyu Feng

  • Guangying Huo

  • Hailiang Liu

  • Hua Jiang

  • Zhongmin Liu

  • July 13, 2026

Share

  • 1

    HUC-MSCs exhibit immunomodulatory properties that may address immune dysfunction in frail elderly populations.

  • 2

    A longitudinal scRNA-seq study revealed HUC-MSCs induce a time-dependent recalibration of the immune system.

  • 3

    The therapy led to a transient expansion of MAIT cells and a sustained reduction in B cell hyperactivity.

  • 4

    Immunomodulatory changes correlated with clinical improvements in grip strength and gait speed among participants.

  • 5

    HUC-MSCs may restore immune homeostasis in aging frailty through sequential, multi-faceted immunomodulation.

Original Source(s)

Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty

  • by Ce Huang, Yingqian Zhu, Xue Gong, Shengyu Feng, Guangying Huo, Hailiang Liu, Hua Jiang, Zhongmin Liu

  • July 13, 2026

Related Content

Mental Health May Impact Dermatologic Quality of Life

Poorer dermatology-related quality of life was associated with greater mental health issues, while habitual probiotic intake showed no measurable relationship with these outcomes.

10 CMS and FDA Actions Affecting Care in 2026

From Medicare payment updates to drug approvals and device access, these federal actions may affect reimbursement, prescribing, patient access, and clinical workflows.

Can AI Aid Urine Drug Test Sign-Outs?

Researchers reported that an artificial intelligence workflow maintained high interpretive accuracy while reducing urine drug test sign-out time in a supervised clinical laboratory setting.